SCHEMBL19645304

SCHEMBL19645304

CC(C)(C)OC(=O)n1c(B(O)O)cc2c(Cl)c(O)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 3/20 0.38
GABRB3 P28472 3/20 0.38
GABRA5 P31644 3/20 0.38
GABRA1 P14867 2/20 0.36
GABRA2 P47869 1/20 0.36
GABRA6 Q16445 1/20 0.36
HTR6 P50406 1/20 0.34
NR1H2 P55055 9/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
CCNB2 O95067 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
GSK3B P49841 1/20 0.33
CCNB3 Q8WWL7 1/20 0.33
ESR2 Q92731 1/20 0.33
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12422263 0.88 GABRG2 (0.38) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL1550722 0.82 GABRG2 (0.37) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL599783 0.81 NR1H2 (0.40) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL29954668 0.77 NR1H2 (0.40) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL29955454 0.77 NR1H2 (0.39) GABRG2GABRB3GABRA5GABRA1NR1H2
SCHEMBL2878161 0.77 NR1H2 (0.40) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL2930214 0.77 NR1H2 (0.39) GABRG2GABRB3GABRA5GABRA1NR1H2
SCHEMBL2873485 0.76 NR1H2 (0.40) GABRG2GABRB3GABRA5GABRA1GABRA2
SCHEMBL17690271 0.75 ESR2 (0.40) GABRG2GABRB3GABRA5HTR6NR1H2
SCHEMBL2926879 0.75 NR1H2 (0.40) GABRG2GABRB3GABRA5NR1H2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828378-B2 Kinase inhibitors and methods of use INTELLIKINE LLC (US) 2017-11-28 US disclosed